Gradual declination of IGF-1 over a year after transsphenoidal adenomectomy of GH producing pituitary adenomas

To know the longitudinal shift of blood IGF-1 of cured acromegaly, we conducted retrospective survey of changes in blood IGF-1 over two years, which has not been previously investigated. Blood IGF-1 levels were measured for longer than 2 years after TSS in 37 patients whose nadir GH during postopera...

Full description

Saved in:
Bibliographic Details
Published inENDOCRINE JOURNAL Vol. 58; no. 12; pp. 1087 - 1091
Main Authors Fujio, Shingo, Tokimura, Hiroshi, Hanaya, Ryosuke, Hirano, Hirofumi, Arita, Kazunori, Yunoue, Shunji, Bohara, Manoj, Arimura, Hiroshi, Kinoshita, Yasuyuki, Tominaga, Atsushi
Format Journal Article
LanguageEnglish
Published Japan The Japan Endocrine Society 2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To know the longitudinal shift of blood IGF-1 of cured acromegaly, we conducted retrospective survey of changes in blood IGF-1 over two years, which has not been previously investigated. Blood IGF-1 levels were measured for longer than 2 years after TSS in 37 patients whose nadir GH during postoperative oral glucose tolerance test (OGTt) was under 1 ng/mL. Blood IGF-1 very gradually declined after three months; 230.6 (mean) ng/mL at 3-12 months, 202.3 ng/mL at 12-24 months, and 198.6 ng/mL at 24-36 months. Their SD values, calculated based on standard IGF-1 values of age- and sex-matched Japanese population, also slowly decreased after three months; 1.69 (mean) at 3-12 months, 1.23 at 12-24 months, and 1.12 at 24-36 months. Very slow decrease of the IGF-1 levels continued beyond the first several months and even the first year after TSS. The declination of values is greater than that associated with aging. This declination may be at least partially a reflection of the slow decrease and late normalization of GH secretion.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0918-8959
1348-4540
DOI:10.1507/endocrj.EJ11-0146